Worth Venture Partners »

Syndax Pharmaceuticals shares owned by Worth Venture Partners

Quarter-by-quarter ownership of Syndax Pharmaceuticals (SNDX) shares owned by Worth Venture Partners from 13F filings

Historical chart of Worth Venture Partners investment in Syndax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syndax Pharmaceuticals held by Worth Venture Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syndax Pharmaceuticals by Worth Venture Partners

Quarter filed Position value Share count Share price at filing
2023-09-30 $158k 11k 14.52
2023-06-30 $228k 11k 20.93

More positions owned by Worth Venture Partners

Csg Sys Intl Note 3.875% 9/1 (Principal)
Guess Note 3.750% 4/1 (Principal)
Radcom Shs New (RDCM)
Opera Sponsored Ads (OPRA)
Silicom Ord (SILC)
Adtran Holdings (ADTN)
Arteris (AIP)
Perpetua Resources (PPTA)
Pagaya Technologies Cl A New (PGY)
Allot SHS (ALLT)
Cto Realty Growth (CTO)
Zeta Global Holdings Corp Cl A (ZETA)
Techtarget Com New (TTGT)
Barclays Bank Ipath S&p 500 Sh (VXX)
Digital Turbine Com New (APPS)

View all positions for Worth Venture Partners

Top funds holding Syndax Pharmaceuticals

BlackRock
Kynam Capital Management
Vanguard Group
Goldman Sachs Group
Point72 Asset Management
State Street Corporation
Eversept Partners
Adage Capital Partners GP
Kingdon Capital Management
Franklin Resources
Geode Capital Management
Soleus Capital Management
Qube Research & Technologies
Catalio Capital Management
Woodline Partners

View all funds holding Syndax Pharmaceuticals